| 1 | 98930-01-9 | N(alpha)-fmoc-N(omega)-mtr-L-arginine | C31H36N4O7S | 608.71 | | |
| 2 | 98930-06-4 | H-TYR(SO3H)-OH SODIUM SALT | C9H10NNaO6S | 283.23 | | |
| 3 | 98930-66-6 | cis-4-Decenoyl carnitine | C17H31NO4 | | | |
| 4 | 98930-70-2 | BIOCYTIN HYDROCHLORIDE | C16H29ClN4O4S | 408.94 | | |
| 5 | 98930-71-3 | 3-(N-maleimidopropionyl)biocytin | C23H33N5O7S | 523.608 | | |
| 6 | 98930-79-1 | MDL 20828 | C17H19N3O6S | 393.41 | | |
| 7 | 98930-96-2 | 1-(3,4-dichlorophenyl)-2,2-dimethylpropan-1-ol | C11H14Cl2O | 233.13 | | |
| 8 | 98931-06-7 | 6-CYANO-1-PROPYL-6-NORFESTUCLAVINE | C19H23N3 | 293.41 | | |
| 9 | 98931-07-8 | 1-ALLYL-6-CYANO-6-NORFESTUCLAVINE | C19H21N3 | 291.39 | | |
| 10 | 98931-09-0 | Ergoline, 8-methyl-1-(2-propenyl)-, (8β)- (9CI) | C18H22N2 | 266.38 | | |
| 11 | 98931-10-3 | Ergoline, 8-methyl-6-(2-propenyl)-, (8-beta)- | C18H22N2 | | | |
| 12 | 98931-11-4 | Ergoline, 8-methyl-6-(2-propenyl)-1-propyl-, (8β)- (9CI) | C21H28N2 | 308.46 | | |
| 13 | 98931-12-5 | Ergoline, 8-methyl-1,6-di-2-propenyl-, (8β)- (9CI) | C21H26N2 | 306.44 | | |
| 14 | 98932-70-8 | CONCANAMYCIN A | C46H75NO14 | 866.09 | | |
| 15 | 98935-61-6 | 1H-Indole-5-acetic acid, 1-methyl- | C11H11NO2 | 189.21 | | |
| 16 | 98935-65-0 | Dimethyl (2S,4R)-piperidine-2,4-dicarboxylate | C9H15NO4 | 201.22 | | |
| 17 | 98935-66-1 | 2,5-Piperidinedicarboxylic acid, 2,5-dimethyl ester, (2R,5R)-rel- | C9H15NO4 | 201.22 | | |
| 18 | 98935-68-3 | 2,5-Piperidinedicarboxylic acid, diMethyl ester, trans- (9CI) | C9H15NO4 | 201.2197 | | |
| 19 | 98936-77-7 | β-Acetoxyisovalerylshikonin | C23H26O8 | 430.45 | | |
| 20 | 98937-00-9 | N-(2,6-dichlorophenyl)-5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide | C13H11Cl2N5O2S | | | |